Kongtim, P., Adekola, K., Milton, D. R., Ramlal, R., Jimenez, A., Chen, J., . . . Ciurea, S. O. (2017). Donor type, in Addition to Transplantation in Chronic Phase and Myeloablative Conditioning, Influence Transplant Survival for Patients with Advanced Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors. Leukemia.
Stile di citazione ChicagoKongtim, Piyanuch, et al. "Donor Type, in Addition to Transplantation in Chronic Phase and Myeloablative Conditioning, Influence Transplant Survival for Patients With Advanced Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors." Leukemia 2017.
Citazione MLAKongtim, Piyanuch, et al. "Donor Type, in Addition to Transplantation in Chronic Phase and Myeloablative Conditioning, Influence Transplant Survival for Patients With Advanced Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors." Leukemia 2017.